Kiro provides an AI-powered digital health platform for clinical biology that interprets laboratory data and generates medically validated reports within seconds. Developed in partnership with laboratories, hospitals and physicians, its solutions offer personalized results for patients and caregivers and deliver real-time clinical decision support tools for prevention and diagnosis. The platform leverages laboratory results to improve patient outcomes and to help healthcare providers follow and treat patients more efficiently. Founded in 2019 and led by CEO Alexandre Guenoun, Kiro is based in Paris, France. The company plans to use the Series A proceeds to further develop its technology and platform, reinforce its position in France, expand commercial operations across Europe, and prepare entry into the US market. The round brought the company's total funding to €17M.

Total raised

$15M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2023